PTSD Trial, Recruiting NCT06538246 Sponsor: Duke University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06538246
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been cared for in an intensive care unit (ICU) or a step-down unit for at least 24 hours
  • People who have had a serious, sudden heart or breathing problem during that hospital stay — this could include being on a breathing machine, receiving oxygen support, being treated for shock, or showing signs of a heart attack, among other conditions (confirm with trial site for full list)
  • People with no history of significant memory or thinking problems (such as dementia), based on their medical records
  • People with no history of serious mental illness (such as psychosis, schizophrenia, or bipolar disorder) and no hospitalisation for a psychiatric condition in the six months before this hospital stay
  • People who are not experiencing thoughts of suicide at the time of admission or when giving consent to join the study
  • People who can speak and understand English or Spanish well enough to watch videos and complete surveys
  • People who, after returning home from hospital, score 8 or higher on a standard questionnaire measuring anxiety and distress (called the HADS scale) — this is checked after discharge

Who may not be able to join:

  • People with active alcohol or drug abuse problems (for example, being admitted for alcohol withdrawal or having a positive drug test at admission)
  • People expected to have complex medical needs after leaving hospital, such as upcoming surgery, new chemotherapy, new dialysis, or being close to giving birth
  • People whose care plan is focused on comfort care rather than active treatment
  • People expected to be discharged to a nursing home, rehabilitation facility, long-term care facility, or home hospice rather than returning independently to their own home
  • People expected to face significant practical barriers after discharge, such as major travel, an unstable living situation, or being unable to use a mobile app
  • People whose thinking or decision-making remains significantly impaired as a result of their illness (assessed using a short cognitive screening test)
  • People who are currently imprisoned, incarcerated, or under home detention
  • People who do not have a reliable smartphone with mobile data or internet access
  • People currently taking part in another study whose goals conflict with this one
  • People who have previously taken part in this trial
  • People who are readmitted to hospital before being enrolled into the study after discharge
  • People who are not enrolled within 14 days of the planned start date after discharge

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher Cox, Professor of Medicine

Phone: 919-681-7232

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
15 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hospital Anxiety and Depression Scale (HADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov